FindTrial
Sign In

Use of Hyperbaric Bupivacaine in spinal for analgesia in laparoscopic cholecystectomy

Efficacy and safety of Hyperbaric Bupivacaine in segmental thoracic spinal for perioperative analgesia in patients undergoing laparoscopic cholecystectomy - TSS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/06/043432
Enrollment
50
Registered
2022-06-22
Start date
Unknown
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K801- Calculus of gallbladder with othercholecystitis

Interventions

Intervention1: spinal anesthesia: segmental spinal anesthesia will be given at thoracic level with using drug 1 ml of 0.5% hyperbaric bupivacaine. spinal anesthesia is commonly used for abdominal and

Sponsors

government medical college haldwani
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: all patients of age 18-60 yrs of ASA 1 or 2 who are coming for laparoscopic cholecystectomy.

Exclusion criteria

Exclusion criteria: 1. Patients who refused to give consent 2. ASA grade >2 3. Contraindication to spinal anesthesia 4. Expected duration of surgery more than 1 hours

Design outcomes

Primary

MeasureTime frame
1.To compare post operative analgesic requirementTimepoint: 0 mins, 1hrs,2hrs, 3hrs, 6 hrs—

Secondary

MeasureTime frame
1.To compare perioperative hemodynamic changes 2.To study other adverse effects Timepoint: 0 mins, 5 mins, 10 mins, 15mins, 30 mins, 1hrs, 2hrs, 3hrs, 6hrs—

Countries

India

Contacts

Public ContactNeelam Sharma

government medical college, Haldwani

neelighata@gmail.com9456696179

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026